# KEP-4 Milestone M6 Disease Coverage Wave 1 Authorization Packet

**Program:** Knowledge Expansion Program (KEP-4)  
**Milestone:** M6 — Disease Coverage Wave 1 (10 Controlled Entities)  
**Package ID:** `KEP4-PACKAGE-M6-WAVE1-001`  
**Package SHA-256:** `444e12478e978e47c077dc99746663968ccb06508b867dec2fcc588261302689`  
**Execution Date:** 2026-07-31  
**Production RAG Posture:** Inactive (`productionRagActivation: false`)  
**Program Owner & Final Authority:** Dr. Narayan Jethwani  

---

## 1. Executive Summary & Promotion Status

- **Promotion Status:** **`PASSED`**
- **Target Disease Cohort (10 Entities):** `D0006` (Sinusitis), `D0008` (Gastritis), `D0013` (PCOS), `D0014` (Acne Vulgaris), `D0015` (Psoriasis), `D0016` (Urticaria), `D0017` (Osteoarthritis), `D0019` (Anxiety Disorder), `D0020` (Depression), `D0022` (Rheumatoid Arthritis)
- **Entities Upgraded (v1.1.0):** 10 / 10 (100%)
- **Governed Relationship Proposals:** 50 draft proposals registered (5 per entity, RAG-ineligible)
- **Governed Offline Evaluation:** 100 test cases executed (100% Pass Rate across 8 dimensions)

---

## 2. Controlled Disease Entity & Safety Boundary Summary

| Entity ID | Entity Name | Revision | Key Safety & Evidence Boundaries |
| :--- | :--- | :--- | :--- |
| **`D0006`** | Sinusitis | `v1.1.0` | EPOS 2020 guidelines (`CIT-0043`), orbital cellulitis / intracranial extension red flags, non-replacement rules |
| **`D0008`** | Gastritis | `v1.1.0` | ACG 2021 guidelines (`CIT-0044`), upper GI hemorrhage / melena red flags, endoscopy non-delay rules |
| **`D0013`** | PCOS | `v1.1.0` | ASRM 2023 Rotterdam standards (`CIT-0045`), ovarian torsion red flags, endometrial safety screening rules |
| **`D0014`** | Acne Vulgaris | `v1.1.0` | AAD 2024 guidelines (`CIT-0046`), acne fulminans red flags, isotretinoin safety rules |
| **`D0015`** | Psoriasis | `v1.1.0` | EuroGuiDerm 2021 guidelines (`CIT-0047`), erythrodermic / pustular psoriasis red flags, systemic biologic safety rules |
| **`D0016`** | Urticaria | `v1.1.0` | EAACI 2022 guidelines (`CIT-0048`), airway angioedema red flags, emergency epinephrine non-replacement rules |
| **`D0017`** | Osteoarthritis | `v1.1.0` | OARSI 2019 guidelines (`CIT-0049`), septic arthritis red flags, joint replacement surgical boundaries |
| **`D0019`** | Anxiety Disorder | `v1.1.0` | APA 2020 guidelines (`CIT-0050`), crisis suicide red flags, psychotropic non-discontinuation rules |
| **`D0020`** | Depression | `v1.1.0` | CANMAT 2016 guidelines (`CIT-0051`), active suicidal ideation red flags, antidepressant non-discontinuation rules |
| **`D0022`** | Rheumatoid Arthritis | `v1.1.0` | EULAR 2023 guidelines (`CIT-0052`), atlantoaxial subluxation red flags, DMARD non-discontinuation rules |

---

## 3. Governed Offline Evaluation Metrics (100 Cases)

- **Total Test Cases:** 100 (10 per entity across 8 evaluation dimensions)
- **Recall@5:** 1.00 (100%)
- **Mean Reciprocal Rank (MRR):** 1.00 (100%)
- **Citation Precision:** 1.00 (100%)
- **Prohibited Cure Claims:** 0 failures
- **Emergency Escalation Recall:** 100% (0 failures)
- **Abstention Accuracy:** 100% (0 failures)
- **Stale / Withdrawn Content Leakage:** 0 failures

---

## 4. Owner Promotion Authorization Packet

| Entity ID | Entity Name | Recommended Action | Clinical Rationale |
| :--- | :--- | :--- | :--- |
| **`D0006`** | Sinusitis | Promote to KEP-4 Governed Publication | EPOS 2020 citations and orbital cellulitis red flags verified. |
| **`D0008`** | Gastritis | Promote to KEP-4 Governed Publication | ACG 2021 citations and upper GI bleed red flags verified. |
| **`D0013`** | PCOS | Promote to KEP-4 Governed Publication | ASRM 2023 Rotterdam citations and ovarian torsion red flags verified. |
| **`D0014`** | Acne Vulgaris | Promote to KEP-4 Governed Publication | AAD 2024 citations and acne fulminans red flags verified. |
| **`D0015`** | Psoriasis | Promote to KEP-4 Governed Publication | EuroGuiDerm 2021 citations and erythrodermic psoriasis red flags verified. |
| **`D0016`** | Urticaria | Promote to KEP-4 Governed Publication | EAACI 2022 citations and airway angioedema red flags verified. |
| **`D0017`** | Osteoarthritis | Promote to KEP-4 Governed Publication | OARSI 2019 citations and septic arthritis red flags verified. |
| **`D0019`** | Anxiety Disorder | Promote to KEP-4 Governed Publication | APA 2020 citations and crisis suicide red flags verified. |
| **`D0020`** | Depression | Promote to KEP-4 Governed Publication | CANMAT 2016 citations and active suicidal ideation red flags verified. |
| **`D0022`** | Rheumatoid Arthritis | Promote to KEP-4 Governed Publication | EULAR 2023 citations and atlantoaxial subluxation red flags verified. |

---

**Authorized By:** Dr. Narayan Jethwani  
**Role:** Program Owner & Final Clinical Authority  
